SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-012546
Filing Date
2021-02-19
Accepted
2021-02-19 19:10:22
Documents
1
Period of Report
2021-02-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 9191
  Complete submission text file 0001209191-21-012546.txt   10527
Mailing Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158
Business Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158 415-978-1200
FIBROGEN INC (Issuer) CIK: 0000921299 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O FIBROGEN, INC. 409 ILLINOIS ST., SAN FRANCISCO CA 94158
Business Address
Kurkijarvi Kalevi (Reporting) CIK: 0001621333 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36740 | Film No.: 21657770